| Bioactivity | (2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective JAK3 inhibitor (IC50=144.8 nM) extracted from patent US20150158864A1, example 68[1]. |
| Name | (2R,5S)-Ritlecitinib |
| CAS | 1792180-79-0 |
| Formula | C15H19N5O |
| Molar Mass | 285.34 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Atli Thorarensen, et al. Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyr-rolo[2,3-d]pyridinyl acrylamides. US20150158864A1. |
(2R,5S)-Ritlecitinib
CAS: 1792180-79-0 F: C15H19N5O W: 285.34
(2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective JAK3 inhibitor (IC50=144.8 nM) extracted from
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.